Obesity is a chronic metabolic and genetic disease which involves accumulation of unnecessary or unusual fat in the body. It is mainly caused by increased fatty intake, reduced physical exercises and genetic inheritance. According to the World Health Organization (WHO), person having body mass index (BMI) more than 30 is considered as an obese. Obesity surgeries, also known as bariatric surgery, decrease the size of stomach by implanting gastric band or intragastric balloon in it, in order to limit the amount of food human stomach can hold. It limits the quantity of food consumers can ingest, which leads to severe weight loss.
Obesity surgeries has an advantageous effect on many medical conditions such as acid reflux, diabetes, low back pain, sleep apnea, acid reflux, polycystic ovary syndrome (PCOS), hypertension and urinary stress incontinence. Obesity surgeries result in 40% to 80% weight loss after two to three years, depending on the way obesity surgery had been proposed. Increasing prevalence of obesity among children and adults is creating a threat in developed and developing nations. Some of the surgical instruments used in obesity surgery are Aesculap, ConMed EndoSurgery, Wilson-Cook Medical, Karl Storz, and Silhouette Medical.
On the basis of procedure, global obesity surgery devices market can be categorized as biliopancreatic diversion with duodenal switch, adjustable gastric banding, Roux-en-Y gastric bypass and sleeve gastrectomy. Based on the various device types, the global obesity surgery devices market can be categorized as intragastric balloons, gastric electrical stimulators, gastric bands and staples.
North America dominates the global obesity surgery devices markets followed by Europe and Asia-Pacific. The dominance in North America region is attributed to high population of obese and rising public awareness towards the ill effect of obesity in the region; also, growing demand for less invasive procedures and obesity treatment in the region. According to the U.S. Centre for Disease Control and Prevention (CDC), 68% of the total adult population in the U.S. is obese.
Request for Table of Content at: https://www.psmarketresearch.com/market-analysis/obesity-surgery-devices-market/toc-sample
Some of the major competitors in obesity surgery devices market are, Medtronic plc, Johnson & Johnson Services Inc, Covidien, Allergan Inc., W.L. Gore & Associates Inc, Olympus Corporation, USGI Medical Inc., Spatz FGIA Inc., IntraPace Inc., ReShape Medical Inc., Satiety Inc., Aspire Bariatrics LLC, and MetaCure Limited.
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.
As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.
Manager – Client Partner
347, 5th Ave. #1402
New York City, NY – 10016
Toll-free: +1-888-778-7886 (USA/Canada)